Share

Global Disease Challenges

hile the world continues to face ongoing challenges with HIV and tuberculosis, and many unknown and emerging threats, there is also an increasing shift in burden of disease toward noncommunicable diseases (NCDs) and mental health. At Johnson & Johnson, we are passionate about our work to save and improve people’s lives. We forge partnerships and identify new ways to pioneer human ingenuity to accelerate the development of new drug regimens, support the strengthening of healthcare systems and break down barriers to access in resource-limited settings.

Global Disease Challenges
expand

Our Aspiration: A world where innovations and holistic health solutions prevent, control and eliminate global disease challenges and epidemics.

5-Year Target: 175 million individuals will have benefited from J&J solutions that prevent, control and eliminate global diseases.

Our Impact:

New Pediatric Formulation of Janssen’s Treatment for Intestinal Worms Achieves World Health Organization Prequalification

“I Was on the Ground During the HIV Epidemic": Interview with Paul Stoffels

Ending MDR-TB: “It’s Doable. Let’s Solve It”

Read More

Related Content

Johnson & Johnson has signed up to the 2030 UN Sustainable Development Goals—the world’s road map for progress.
This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue